Tightline Development, LLC
5883 Glenridge Dr., Suite 175
Atlanta, GA 30328
Patents and Trademark:
The Exodus Revision Hip System facilitates stem bone interface disruption that is significantly improved over traditional techniques and is designed for minimal bone loss with minimal effort and minimal damage to the proximal femur, compared to an extended trochanteric osteotomy.
Bactisure Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed (jet) lavage. The clear, colorless, low-odor solution is a FDA 510(K) cleared device. Active ingredients include ethanol (solvent), acetic acid (pH modifier), sodium acetate (buffer), benzalkonium chloride (surfactant), and water. Bactisure Wound Lavage is available in sterile 1000 mL polypropylene plastic bags with an integrated single spike port.
Exodus is a trademark of Tightline Development.
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert or contact your local representative; search this website for additional product information. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.